This is a Validated Antibody Database (VAD) review about mouse Cd69, based on 262 published articles (read how Labome selects the articles), using Cd69 antibody in all methods. It is aimed to help Labome visitors find the most suited Cd69 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Cd69 synonym: 5830438K24Rik; AI452015; AIM; VEA

BioLegend
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4d
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 4d). Front Cell Infect Microbiol (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Cd69 antibody (BioLegend, 104512) was used in flow cytometry on mouse samples (fig 2a). Sci Adv (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2d, 6b, s6i
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 2d, 6b, s6i). Proc Natl Acad Sci U S A (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2k, 3e
BioLegend Cd69 antibody (BioLegend, 104506) was used in flow cytometry on mouse samples (fig 2k, 3e). J Immunother Cancer (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:400; loading ...; fig 7b, 7j
BioLegend Cd69 antibody (BioLegend, 104508) was used in flow cytometry on mouse samples at 1:400 (fig 7b, 7j). elife (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend Cd69 antibody (BioLegend, 104516) was used in flow cytometry on mouse samples (fig 5c). J Clin Invest (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:50; fig 5g
BioLegend Cd69 antibody (BioLegend, 104507) was used in flow cytometry on mouse samples at 1:50 (fig 5g). EMBO Mol Med (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Cd69 antibody (BioLegend, 104523) was used in flow cytometry on mouse samples (fig 1e). Sci Immunol (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; loading ...; fig s1b
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples at 1:100 (fig s1b). J Immunother Cancer (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 6a
BioLegend Cd69 antibody (Biolegend, 104541) was used in flow cytometry on mouse samples (fig 6a). Cell Death Dis (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples . Am J Physiol Endocrinol Metab (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; human; loading ...
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend Cd69 antibody (Biolegend, 104513) was used in flow cytometry on mouse samples (fig 3d). Mol Cancer (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s1b
BioLegend Cd69 antibody (Biolegend, 104505) was used in flow cytometry on mouse samples (fig s1b). Transl Oncol (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend Cd69 antibody (Biolegend, 104508) was used in flow cytometry on mouse samples (fig s2b). J Clin Invest (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4c
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 4c). Adv Sci (Weinh) (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Cd69 antibody (BioLegend, 104514) was used in flow cytometry on mouse samples (fig 2a). Mucosal Immunol (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5d, 5e
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 5d, 5e). Transl Oncol (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s2a, s2b, s2c
BioLegend Cd69 antibody (Biolegend, 104508) was used in flow cytometry on mouse samples (fig s2a, s2b, s2c). Proc Natl Acad Sci U S A (2021) ncbi
hamsters monoclonal (H1.2F3)
  • mass cytometry; mouse; loading ...
BioLegend Cd69 antibody (BioLegend, 104533) was used in mass cytometry on mouse samples . Br J Cancer (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2c
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 2c). J Immunother Cancer (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 6a, 6c
BioLegend Cd69 antibody (Biolegend, 104514) was used in flow cytometry on mouse samples (fig 6a, 6c). Cancer Res (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3c
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). J Immunother Cancer (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:50; loading ...; fig 3c
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples at 1:50 (fig 3c). Science (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 7a, 7b
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 7a, 7b). J Clin Invest (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s3c
BioLegend Cd69 antibody (BioLegend, 104510) was used in flow cytometry on mouse samples (fig s3c). Cell (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:250; loading ...; fig 4g
  • immunohistochemistry; mouse; loading ...; fig 2a
BioLegend Cd69 antibody (Biolegend, 104506) was used in flow cytometry on mouse samples at 1:250 (fig 4g) and in immunohistochemistry on mouse samples (fig 2a). elife (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2s1a
BioLegend Cd69 antibody (Biolegend, 104525) was used in flow cytometry on mouse samples (fig 2s1a). elife (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3g
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 3g). Adv Sci (Weinh) (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 2 ug/ml; loading ...; fig s29b
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples at 2 ug/ml (fig s29b). Science (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s4f, s6b
BioLegend Cd69 antibody (Biolegend, 104537) was used in flow cytometry on mouse samples (fig s4f, s6b). Nat Commun (2020) ncbi
hamsters monoclonal (H1.2F3)
  • mass cytometry; mouse; 6 ug/ml; loading ...; fig 5d
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in mass cytometry on mouse samples at 6 ug/ml (fig 5d). Science (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Cd69 antibody (Biolegend, 104507) was used in flow cytometry on mouse samples (fig 6a). Cell Rep (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; loading ...; fig 2d
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples at 1:200 (fig 2d). Cell Rep (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3
BioLegend Cd69 antibody (Bio-Legend, H1.2F3) was used in flow cytometry on mouse samples (fig 3). BMC Infect Dis (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Cd69 antibody (Biolegend, 104512) was used in flow cytometry on mouse samples (fig 2c). Cell Rep (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend Cd69 antibody (BioLegend, 104507) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s6e
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig s6e). Science (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s3k
BioLegend Cd69 antibody (BioLegend, 104517) was used in flow cytometry on mouse samples (fig s3k). Nature (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s6
BioLegend Cd69 antibody (BioLegend, 104527) was used in flow cytometry on mouse samples (fig s6). Cell Rep (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Cd69 antibody (Biolegend, 104508) was used in flow cytometry on mouse samples (fig 5a). Cell (2019) ncbi
hamsters monoclonal (H1.2F3)
  • mass cytometry; mouse; loading ...; fig 3, s2
BioLegend Cd69 antibody (Biolegend, 104533) was used in mass cytometry on mouse samples (fig 3, s2). Science (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; loading ...; fig ex5a
BioLegend Cd69 antibody (BioLegend, 104512) was used in flow cytometry on mouse samples at 1:200 (fig ex5a). Nature (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s1d
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig s1d). Cell Rep (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s6a
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig s6a). Science (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; loading ...; fig 2c
BioLegend Cd69 antibody (Biolegend, 104513) was used in flow cytometry on mouse samples at 1:100 (fig 2c). Nat Commun (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2g
BioLegend Cd69 antibody (Biolegend, 104541) was used in flow cytometry on mouse samples (fig 2g). Cell (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c
BioLegend Cd69 antibody (Biolegend, 104522) was used in flow cytometry on mouse samples at 1:200 (fig 1c). elife (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend Cd69 antibody (Biolegend, 104527) was used in flow cytometry on mouse samples (fig 5d). Cell (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; loading ...; fig 4b
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples at 1:100 (fig 4b). Biosci Rep (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2f
BioLegend Cd69 antibody (BioLegend, 104523) was used in flow cytometry on mouse samples (fig 2f). Cell (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; loading ...; fig s3a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples at 1:200 (fig s3a). Nat Commun (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 1c). J Immunol Res (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 5b). Front Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4g
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 4g). J Exp Med (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 2e). J Virol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 7a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 7a). J Clin Invest (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 5a). Cell Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1h
BioLegend Cd69 antibody (BioLegend, 104514) was used in flow cytometry on mouse samples (fig 1h). Cell (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3
BioLegend Cd69 antibody (Biolegend, 104508) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s10b
In order to evaluate mouse models of hepacivirus infection, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig s10b). Science (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the effect of lymphatic endothelial S1P on mitochondrial function and naive T cell survival, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig s2a). Nature (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 3a). J Clin Invest (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3a
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend Cd69 antibody (biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 3a). J Exp Med (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s8c
In order to investigate how aging affects transcriptional dynamics in naive and CD4 positive T cells, BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig s8c). Science (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 1c). Front Immunol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 4a). Immunology (2017) ncbi
hamsters monoclonal (H1.2F3)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1e
  • flow cytometry; mouse; loading ...; fig 5a
In order to elucidate how P2X7 regulates the contraction of intestinal CD4 positive effector T cells, BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in immunohistochemistry - frozen section on mouse samples (fig 1e) and in flow cytometry on mouse samples (fig 5a). Mucosal Immunol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 7f
In order to examine skin dendritic cells from mice exposed to two different Th2 stimuli, BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 7f). J Exp Med (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 6c
In order to optimize the delivery of drugs to the immune compartment via CD11a and generate tissue-targeted PDE4 inhibitors, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 6c). Mol Ther (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3
BioLegend Cd69 antibody (BioLegend, 104513) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s1
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend Cd69 antibody (BioLegend, 104512) was used in flow cytometry on mouse samples (fig s1). Cell (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig S1
In order to study the effect of IL-10 signaling in infectious neurological diseases, BioLegend Cd69 antibody (BioLegend, clone H1.2F3) was used in flow cytometry on mouse samples (fig S1). PLoS ONE (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 5a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3
In order to study the functions of WASp knock out natural killer cells, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 3). Sci Rep (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 2a). Cell Biosci (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 5
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 5). Science (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4a
In order to determine the effects of an altered intestinal microbiota and microbial metabolites on graft-versus-host disease, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 4a). Nat Immunol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2b
In order to elucidate the role of B cells in the initiation of central nervous system autoimmunity, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4e
In order to research the role of Tim-1 and Tim-4 blockade in the atherosclerotic pathogenesis, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 4e). Arterioscler Thromb Vasc Biol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s5
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig s5). EMBO Mol Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:400; loading ...; fig s1c
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, BioLegend Cd69 antibody (BioLegend, 104508) was used in flow cytometry on mouse samples at 1:400 (fig s1c). Nat Commun (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1
In order to determine the promotion of the formation of conjugates between transformed T helper cells and B lymphoma cells by murid gammaherpesvirus latency-associated protein M2, BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1
In order to research skin-resident memory T cell homeostasis and lymphoma mediated by hair follicle-derived IL-7 and IL-15, BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 1). Nat Med (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 6a). J Virol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3h
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 3h). J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3a
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 3a). J Leukoc Biol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to elucidate the role of Treg during T. gondii infection, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples . Microbes Infect (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 6
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 6). J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples . Biochem Biophys Res Commun (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to report that AMPK regulates protein phosphatase activity to control the of survival and function of CD8+ T cells, thus regulating immune surveillance of tumors, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples . Oncotarget (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1
BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples . J Clin Invest (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 5
In order to study the contribution of SEMA4D-PLXNB1 interactions to immune-cell trafficking in the tumor microenvironment, BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 5). Cancer Immunol Res (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to evaluate a model of cerebral malaria pathogenesis and its effect on the blood brain barrier, BioLegend Cd69 antibody (Biolegend, H1.2F3) was used in flow cytometry on mouse samples . PLoS Pathog (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2
BioLegend Cd69 antibody (BioLegend, H1.2F3) was used in flow cytometry on mouse samples (fig 2). Toxicol Sci (2015) ncbi
Invitrogen
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5f
Invitrogen Cd69 antibody (eBioscience, 25-0691-82) was used in flow cytometry on mouse samples (fig 5f). PLoS Pathog (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1c). Int J Mol Sci (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; loading ...; fig 8a, 8b
Invitrogen Cd69 antibody (Thermo Fisher, H1.2F3) was used in flow cytometry on mouse samples at 1:200 (fig 8a, 8b). Sci Rep (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; loading ...; fig 3c
Invitrogen Cd69 antibody (eBioscience, 13-0691-82) was used in flow cytometry on mouse samples at 1:100 (fig 3c). Nat Commun (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 8f
Invitrogen Cd69 antibody (eBioscience, 14-0691-82) was used in flow cytometry on mouse samples (fig 8f). Cell Mol Gastroenterol Hepatol (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1f, s5, s31
Invitrogen Cd69 antibody (eBioscience, 12-0691-83) was used in flow cytometry on mouse samples (fig 1f, s5, s31). Nat Commun (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...
Invitrogen Cd69 antibody (Thermo Fisher Scientific, H1??2F3) was used in flow cytometry on mouse samples . J Autoimmun (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s3c
Invitrogen Cd69 antibody (eBioscience, 12-0691-83) was used in flow cytometry on mouse samples (fig s3c). Cell (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4c
Invitrogen Cd69 antibody (Thermo Fisher, 25-0691-82) was used in flow cytometry on mouse samples (fig 4c). Cell (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3c
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). BMC Immunol (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3e
Invitrogen Cd69 antibody (eBioscience, 14-0691-82) was used in flow cytometry on mouse samples (fig 3e). elife (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s3
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s3). Nature (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig e4d
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig e4d). Nature (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4b
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 4b). Nature (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen Cd69 antibody (eBioscience, 12-0691-83) was used in flow cytometry on mouse samples (fig 2b). Cell (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1e). J Clin Invest (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3f
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3f). J Immunol (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s4e
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s4e). J Exp Med (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 6q
Invitrogen Cd69 antibody (eBioscience, 47-0691-82) was used in flow cytometry on mouse samples (fig 6q). Cell Rep (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1f
Invitrogen Cd69 antibody (BD, 12-0691-81) was used in flow cytometry on mouse samples (fig 1f). Nat Commun (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen Cd69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:6; fig s2c
Invitrogen Cd69 antibody (ThermoFisher, H1.2F3) was used in flow cytometry on mouse samples at 1:6 (fig s2c). PLoS Pathog (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s6c
Invitrogen Cd69 antibody (eBioscience, 47-0691-82) was used in flow cytometry on mouse samples (fig s6c). Nat Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s3
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s3). Front Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2a
Invitrogen Cd69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 2a). Cancer Cell (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; loading ...; fig 1j
Invitrogen Cd69 antibody (eBioscience, 11-0691-85) was used in flow cytometry on mouse samples at 1:100 (fig 1j). Development (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5c
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 5c). Eur J Immunol (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3a
Invitrogen Cd69 antibody (Thermo Fisher Scientific, 25-0691-82) was used in flow cytometry on mouse samples (fig 3a). Cell (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s6b
In order to investigate the effect of polymicrobial sepsis in skin immune response, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s6b). PLoS Pathog (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2e
In order to investigate the involvement of Sec22b in antigen cross-presentation and antitumor immunity, Invitrogen Cd69 antibody (eBiosciences, 48-0691-82) was used in flow cytometry on mouse samples (fig 2e). J Exp Med (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3
In order to investigate the regulated egress of T-cell subsets from tumors, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1c
In order to investigate the role of Egr2 and 3 in adaptive immune responses and its mechanism, Invitrogen Cd69 antibody (eBiosciences, 12-0691-81) was used in flow cytometry on mouse samples (fig 1c). J Exp Med (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3c
In order to examine the localization and function of FHL2 in natural killer cells, Invitrogen Cd69 antibody (Affymetrix eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). Front Immunol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5d
In order to determine the contribution of B cell to obesity-induced insulin resistance, Invitrogen Cd69 antibody (eBiosciences, 48-0691-80) was used in flow cytometry on mouse samples (fig 5d). J Clin Invest (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; human; loading ...; fig 2d
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on human samples (fig 2d). Am J Transplant (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1f
In order to explore how antigen-dependent pathways modulate skin-resident memory T cell generation, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4c
In order to find that dendritic cells modulate thymic egress, Invitrogen Cd69 antibody (ebioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 4c). J Exp Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3j
In order to study the role of miR-7 in acute lung injury, Invitrogen Cd69 antibody (ebioscience, 17-0691-82) was used in flow cytometry on mouse samples (fig 3j). Front Immunol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2a
In order to elucidate the role of Tbet in acute lung injury, Invitrogen Cd69 antibody (eBioscience, [1H].2F3) was used in flow cytometry on mouse samples (fig 2a). J Leukoc Biol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3c
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). J Exp Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s2c
In order to use knockout mice to determine the role of cereblon in T cells, Invitrogen Cd69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples (fig s2c). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3c
In order to propose that the ERK-AP-1 axis is important for translating TCR signal strength into proportional activation of downstream events, Invitrogen Cd69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). elife (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 4). Oncotarget (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1a
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1a). elife (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2c
Invitrogen Cd69 antibody (eBiosciences, 45-0691) was used in flow cytometry on mouse samples (fig 2c). Nature (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2
In order to establish that autophagy is essential for maintenance of a balanced CD4 positive intestinal T cell response, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s5
Invitrogen Cd69 antibody (eBioscience, 45-0691-82) was used in flow cytometry on mouse samples (fig s5). Sci Rep (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; fig s6b
In order to suggest that locally synthesized C1q promotes tumor growth, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples at 1:100 (fig s6b). Nat Commun (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3
In order to examine the contribution of Foxo1 to activated T cells, Invitrogen Cd69 antibody (eBiocience, H1.2F3) was used in flow cytometry on mouse samples (fig 3). Nature (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s3
Invitrogen Cd69 antibody (eBioscience, 48-0691) was used in flow cytometry on mouse samples (fig s3). Leukemia (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to identify the sequence motif of B class phosphodiester oligodeoxyribonucleotides that govern mouse TLR9 activation, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2b
In order to test if 17-allylamino-demethoxygeldanamycin improves intestinal barrier function using two mouse graft versus host disease models, Invitrogen Cd69 antibody (eBioscience, 17-0691-82) was used in flow cytometry on mouse samples (fig 2b). Oncogene (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s2
In order to test if anti-retroviral natural killer cell functions are inhibited by T regulatory cells during an acute Friend retrovirus infection, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s2). Retrovirology (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3
In order to evaluate as a mucosal vaccine platform against influenza A virus, Invitrogen Cd69 antibody (eBioscience, # 12-0691-82) was used in flow cytometry on mouse samples (fig 3). Front Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2E
In order to explore the roles of T and B cells in chronic graft-versus-host disease, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 2E). Ann Hematol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:500; fig 4
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples at 1:500 (fig 4). Nat Commun (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s7
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig s7). Nat Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; tbl s3
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (tbl s3). PLoS ONE (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 4). Infect Immun (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 6
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 6). PLoS Pathog (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 5
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 5
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 5). J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . Mucosal Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 4). Immunol Lett (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3d,4a
In order to explore the interaction between IL-2 and IL-7 in CD4 T-cell memory generation, Invitrogen Cd69 antibody (ebioscience, H12F3) was used in flow cytometry on mouse samples (fig 3d,4a). Nat Commun (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
Invitrogen Cd69 antibody (eBiosciences, H1.2F3) was used in flow cytometry on mouse samples . Eur J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:300
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples at 1:300. Nat Commun (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; human
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 5
In order to examine the quantitative and temporal requirements of Zap70's function in thymocyte development, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100
In order to study the involvement of endothelium in efficient Treg T cell recruitment in vivo, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to characterize the Treg populations the Friend retrovirus mouse model, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . Virol Sin (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . Diabetes (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . Br J Cancer (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to describe the role of Themis in T cell development, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . Nature (2013) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to investigate the role of BTB-ZF factors in lymphoid effector programs, Invitrogen Cd69 antibody (e-Bioscience, H1.2F3) was used in flow cytometry on mouse samples . Nature (2012) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to study splenic natural killer T cells, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . EMBO J (2012) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . J Immunol (2011) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2
In order to study the role of liver NK cells in virus-induced severe viral hepatitis, Invitrogen Cd69 antibody (eBioscience, [1H].2F3) was used in flow cytometry on mouse samples (fig 2). J Immunol (2010) ncbi
hamsters monoclonal (H1.2F3)
  • immunocytochemistry; mouse
Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in immunocytochemistry on mouse samples . Cell Host Microbe (2009) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to study the strength and duration of an antigenic signal at initial stimulation and the development and response of effectors and memory cells to secondary stimulation with the same antigen, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . Immunology (2008) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; tbl 1
In order to elucidate the role of IL-10 in regulating hepatic injury using IL-10 knockout mice infected with Trichinella spiralis, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples (tbl 1). J Immunol (2007) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to evaluate the use of biodegradable poly(D,L-lactic-co-glycolic acid) nanoparticles as a vaccine delivery system, Invitrogen Cd69 antibody (E-Bioscience, H1.2F3) was used in flow cytometry on mouse samples . J Biomed Mater Res A (2007) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to study recent thymic emigrants in aged mice, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2006) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to study ineffective T cell clonal anergy induction in nu/nu mice, Invitrogen Cd69 antibody (eBioscience, H1.2F3) was used in flow cytometry on mouse samples . J Immunol (2006) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4
Invitrogen Cd69 antibody (eBioscience, 1.2F3) was used in flow cytometry on mouse samples (fig 4). J Immunol (2005) ncbi
Santa Cruz Biotechnology
mouse monoclonal (D-3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4d
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology Cd69 antibody (Santa, sc-373799) was used in immunohistochemistry - paraffin section on human samples (fig 4d) and in western blot on human samples (fig 4b). Cell Mol Life Sci (2022) ncbi
Miltenyi Biotec
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 3 ug/ml; fig st4
In order to find microenvironmental regulators of metastatic colonization, Miltenyi Biotec Cd69 antibody (Miltenyi Biotec, H1.2F3) was used in flow cytometry on mouse samples at 3 ug/ml (fig st4). Nature (2017) ncbi
Tonbo Biosciences
monoclonal (H12F3)
  • flow cytometry; mouse; loading ...; fig 1d
In order to determine the role of CD6 in T cells using knock out mice, Tonbo Biosciences Cd69 antibody (TONBO Bioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2016) ncbi
BD Biosciences
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s3
BD Biosciences Cd69 antibody (BD Bioscience, 553237) was used in flow cytometry on mouse samples (fig s3). Cell Rep (2022) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig ds1k
BD Biosciences Cd69 antibody (BD, 552879) was used in flow cytometry on mouse samples (fig ds1k). Cell Rep (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; loading ...; fig 4e
BD Biosciences Cd69 antibody (BD Biosciences, 552879) was used in flow cytometry on mouse samples at 1:100 (fig 4e). Nat Commun (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1l
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 1l). Cell Death Dis (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 1f, s5, s31
BD Biosciences Cd69 antibody (BD Biosciences, 562920) was used in flow cytometry on mouse samples (fig 1f, s5, s31). Nat Commun (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:250; loading ...; fig 1c
BD Biosciences Cd69 antibody (BD Biosciences, 553236) was used in flow cytometry on mouse samples at 1:250 (fig 1c). Cancer Res (2021) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 8a
BD Biosciences Cd69 antibody (BD Biosciences, H1 2F3) was used in flow cytometry on mouse samples (fig 8a). Front Immunol (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2f
BD Biosciences Cd69 antibody (Biolegend, 553236) was used in flow cytometry on mouse samples (fig 2f). Nat Commun (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s4c
BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples (fig s4c). Science (2020) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2c
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 2c). Science (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5a
BD Biosciences Cd69 antibody (Pharmingen, H1.2F3) was used in flow cytometry on mouse samples (fig 5a). Front Immunol (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s6
BD Biosciences Cd69 antibody (BD Biosciences, 562455) was used in flow cytometry on mouse samples (fig s6). Cell Rep (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig e5b
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig e5b). Nature (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s1
BD Biosciences Cd69 antibody (BD Biosciences, 557392) was used in flow cytometry on mouse samples (fig s1). J Clin Invest (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s7a
BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples (fig s7a). Cancer Immunol Immunother (2019) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; loading ...; fig s7d
BD Biosciences Cd69 antibody (BD Biosciences, 552879) was used in flow cytometry on mouse samples at 1:200 (fig s7d). Nat Neurosci (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s1a
BD Biosciences Cd69 antibody (BD Biosciences, H12F3) was used in flow cytometry on mouse samples (fig s1a). J Clin Invest (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s4d
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig s4d). J Exp Med (2018) ncbi
hamsters monoclonal (H1.2F3)
BD Biosciences Cd69 antibody (BD, H1.2F3) was used . Proc Natl Acad Sci U S A (2018) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3c
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 3c). J Cell Biol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3
In order to investigate the regulated egress of T-cell subsets from tumors, BD Biosciences Cd69 antibody (BD Bioscience, H1.2F3) was used in flow cytometry on mouse samples (fig 3). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 2j
BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples (fig 2j). J Exp Med (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 6d
In order to study the therapeutic TnP peptide in inflammation and demyelination in a mouse model of multiple sclerosis., BD Biosciences Cd69 antibody (BD Biosciences, 551113) was used in flow cytometry on mouse samples (fig 6d). PLoS ONE (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s1b
In order to test if dermal gammadelta cells freely re-circulate out of skin, or behave like dermal resident memory T cells in mice, BD Biosciences Cd69 antibody (BD PharMingen, H1.2F3) was used in flow cytometry on mouse samples (fig s1b). PLoS ONE (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s7e
In order to find microenvironmental regulators of metastatic colonization, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig s7e). Nature (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 7G
In order to analyze the effects of a loss of autophagy in dendritic cells and B cells in a TLR7-mediated model of autoimmunity, BD Biosciences Cd69 antibody (BD Biosciences, 551113) was used in flow cytometry on mouse samples (fig 7G). J Immunol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 5a
In order to discuss the contribution of astrocytic IL-15 to postischemic brain damage, BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples (fig 5a). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 4d
BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples (fig 4d). J Exp Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s3h
BD Biosciences Cd69 antibody (BD Biosciences, 553237) was used in flow cytometry on mouse samples (fig s3h). Nat Immunol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; fig 10
BD Biosciences Cd69 antibody (BD PharMingen, H1.2F3) was used in flow cytometry on mouse samples at 1:100 (fig 10). Nat Commun (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; fig 5
BD Biosciences Cd69 antibody (BD Biosciences, 553236) was used in flow cytometry on mouse samples at 1:100 (fig 5). Nat Commun (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4
BD Biosciences Cd69 antibody (BD, 561929) was used in flow cytometry on mouse samples (fig 4). Front Immunol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 7
BD Biosciences Cd69 antibody (BD Pharmingen, H1.2F3) was used in flow cytometry on mouse samples (fig 7). PLoS ONE (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2D
In order to study the contribution of CXCR6/CXCL16 interactions in glycolipid-dependent invariant natural killer cell activation and tumor control, BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples (fig 2D). Oncoimmunology (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s4b
In order to model the expression patterns of chemokines and cytokines that turn into M1/M2 macrophage activation., BD Biosciences Cd69 antibody (BD Pharmingen, 553237) was used in flow cytometry on mouse samples (fig s4b). PLoS Comput Biol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2
In order to study prevention of allergic skin disease by epidermal RAF, BD Biosciences Cd69 antibody (BD Bioscience, 557392) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s2
In order to study the impact of p21 signaling on monocyte reprogramming, BD Biosciences Cd69 antibody (BD Pharmingen, H1.2F3) was used in flow cytometry on mouse samples (fig s2). J Clin Invest (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; fig 1
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BD Biosciences Cd69 antibody (BD Biosciences, 553235) was used in flow cytometry on mouse samples at 1:200 (fig 1). Nat Immunol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s2b
In order to discuss the environmental and cellular factors that contribute to allergic responses, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig s2b). J Allergy Clin Immunol (2017) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3e
In order to elucidate the role of AMP-activated protein kinase in regulating T cell survival and function, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 3e). Oncotarget (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig s3b
BD Biosciences Cd69 antibody (Beckon Dickinson, 552879) was used in flow cytometry on mouse samples (fig s3b). Biol Open (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:200; fig 6
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples at 1:200 (fig 6). Nat Immunol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BD Biosciences Cd69 antibody (BD-Biosciences, 557392) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 6a
In order to study the role of sprouty-related ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein-2 in influenza a virus-induced pneumonia, BD Biosciences Cd69 antibody (BD Pharmingen, H1.2F3) was used in flow cytometry on mouse samples (fig 6a). Crit Care Med (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to investigate the control of LAT recruitment to the immune synapse and T-cell activation in vivo by IFT20, BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4
In order to study murine nasal passages to identify and analyze natural killer cells, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2
BD Biosciences Cd69 antibody (BD Biosciences, H1.253) was used in flow cytometry on mouse samples (fig 2). J Virol (2016) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig s2b
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig s2b). Nat Med (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2
In order to study apolipoprotein-1 during normocholesterolemic conditions, BD Biosciences Cd69 antibody (BD Pharmingen, H1.2F3) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • immunocytochemistry; mouse
In order to report that carbon monoxide produced by heme-oxygenase 1 impairs DC immunogenicity using a mitochondria-dependent mechanism, BD Biosciences Cd69 antibody (BD Pharmingen, H1.2F3) was used in immunocytochemistry on mouse samples . Eur J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to study mediation of TLR7-dependent inflammation and autoimmunity by B cell autophagy, BD Biosciences Cd69 antibody (BD Biosciences, 551113) was used in flow cytometry on mouse samples . Autophagy (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 10 ug/ml; loading ...; fig 6c
In order to propose that thymoproteasomes contribute to the positive selection of CD8 positive T cells by preferentially producing low-affinity T-cell receptor ligand peptides, BD Biosciences Cd69 antibody (BD Pharmingen, H1.2F3) was used in flow cytometry on mouse samples at 10 ug/ml (fig 6c). Nat Commun (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1
In order to optimize application routes for trifunctional bispecific antibodies against tumor-associated ganglioside GD2, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 1). Mol Cancer Ther (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; 1:100; fig s4
BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples at 1:100 (fig s4). PLoS ONE (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BD Biosciences Cd69 antibody (BD, 553237) was used in flow cytometry on mouse samples . Biochim Biophys Acta (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BD Biosciences Cd69 antibody (BD Biosciences, 553236) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 3
BD Biosciences Cd69 antibody (BD Pharmigen, H1.2F3) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1
In order to test if injury interferes with the differentiation of antigen-specific T helper-cell responses in vivo, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 1). Clin Sci (Lond) (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; loading ...; fig 3d
In order to investigate the ability of PTEN to regulate natural killer cell function, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 3d). J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 1
BD Biosciences Cd69 antibody (BD, clone H1.2F3) was used in flow cytometry on mouse samples (fig 1). Eur J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 2
In order to investigate the role of Rpl22 during early B cell development, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to test if professional antigen-presenting cell subsets and MCMV-encoded evasins alter IFN-I responses, BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples . J Virol (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 5
In order to analyze deubiquitinization Usp9X and its regulation of proximal T cell receptor signaling and tolerance induction, BD Biosciences Cd69 antibody (BD, H1.2F3) was used in flow cytometry on mouse samples (fig 5). J Exp Med (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to study the role of CD93 molecule in mature dendritic cells and T cells, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples . Immunobiology (2015) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
In order to demonstrate that CTLA-4 promotes Tc17 differentiation and robust Tc17 responses, BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse; fig 4
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples (fig 4). Mucosal Immunol (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BD Biosciences Cd69 antibody (BD Biosciences, H1.2F3) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (H1.2F3)
  • flow cytometry; mouse
BD Biosciences Cd69 antibody (BD Bioscience, H1.2 F3) was used in flow cytometry on mouse samples . J Immunol Methods (2013) ncbi
Articles Reviewed
  1. Hou X, Shi Y, Kang X, Rousu Z, Li D, Wang M, et al. Echinococcus granulosus: The establishment of the metacestode in the liver is associated with control of the CD4+ T-cell-mediated immune response in patients with cystic echinococcosis and a mouse model. Front Cell Infect Microbiol. 2022;12:983119 pubmed publisher
  2. Jim xe9 nez Fern xe1 ndez M, Rodr xed guez Sinovas C, Ca xf1 es L, Ballester Servera C, Vara A, Requena S, et al. CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4 + T lymphocytes. Cell Mol Life Sci. 2022;79:468 pubmed publisher
  3. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  4. Laffey K, Stiles R, Ludescher M, Davis T, Khwaja S, Bram R, et al. Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations. Proc Natl Acad Sci U S A. 2022;119:e2118529119 pubmed publisher
  5. Lu L, Li T, Feng X, Liu Z, Liu Y, Chao T, et al. Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice. PLoS Pathog. 2022;18:e1010596 pubmed publisher
  6. Saxena V, Piao W, Li L, Paluskievicz C, Xiong Y, Simon T, et al. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Rep. 2022;39:110727 pubmed publisher
  7. van Vloten J, Matuszewska K, Minow M, Minott J, Santry L, Pereira M, et al. Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer. J Immunother Cancer. 2022;10: pubmed publisher
  8. Lopes N, Boucherit N, Santamaria J, Provin N, Charaix J, Ferrier P, et al. Thymocytes trigger self-antigen-controlling pathways in immature medullary thymic epithelial stages. elife. 2022;11: pubmed publisher
  9. Keller E, Dvorina N, Jørgensen T. Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent. Int J Mol Sci. 2022;23: pubmed publisher
  10. Yang K, Han J, Asada M, Gill J, Park J, Sathe M, et al. Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease. J Clin Invest. 2022;132: pubmed publisher
  11. Zhou Q, Liang J, Yang T, Liu J, Li B, Li Y, et al. Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO Mol Med. 2022;14:e14502 pubmed publisher
  12. Stoff M, Ebbecke T, Ciurkiewicz M, Pavasutthipaisit S, Mayer Lambertz S, St xf6 rk T, et al. C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection. Sci Rep. 2021;11:23819 pubmed publisher
  13. Tatsumi N, Codrington A, El Fenej J, Phondge V, Kumamoto Y. Effective CD4 T cell priming requires repertoire scanning by CD301b+ migratory cDC2 cells upon lymph node entry. Sci Immunol. 2021;6:eabg0336 pubmed publisher
  14. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  15. Xu P, Xiong W, Lin Y, Fan L, Pan H, Li Y. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression. Cell Death Dis. 2021;12:779 pubmed publisher
  16. Petley E, Koay H, Henderson M, Sek K, Todd K, Keam S, et al. MAIT cells regulate NK cell-mediated tumor immunity. Nat Commun. 2021;12:4746 pubmed publisher
  17. Winn N, Wolf E, Cottam M, Bhanot M, Hasty A. Myeloid-specific deletion of ferroportin impairs macrophage bioenergetics but is disconnected from systemic insulin action in adult mice. Am J Physiol Endocrinol Metab. 2021;321:E376-E391 pubmed publisher
  18. Ortega Molina A, Lebrero Fernández C, Sanz A, Deleyto Seldas N, Plata Gómez A, Menéndez C, et al. Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs. Cell Rep. 2021;36:109372 pubmed publisher
  19. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  20. Uyanik B, Goloudina A, Akbarali A, Grigorash B, Petukhov A, Singhal S, et al. Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses. Nat Commun. 2021;12:3622 pubmed publisher
  21. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  22. Pereira J, Cavaco P, da Silva R, Pacheco Leyva I, Mereiter S, Pinto R, et al. P-selectin glycoprotein ligand 1 promotes T cell lymphoma development and dissemination. Transl Oncol. 2021;14:101125 pubmed publisher
  23. Zhang X, Liu X, Zhou W, Du Q, Yang M, Ding Y, et al. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance. Cell Mol Gastroenterol Hepatol. 2021;12:1179-1199 pubmed publisher
  24. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  25. Clemen R, Freund E, Mrochen D, Miebach L, Schmidt A, Rauch B, et al. Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT-II T Cell Activation Conferring Tumor Protection in Mice. Adv Sci (Weinh). 2021;8:2003395 pubmed publisher
  26. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  27. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  28. Li J, Xu J, Li Z. Obatoclax, the pan-Bcl-2 inhibitor sensitizes hepatocellular carcinoma cells to promote the anti-tumor efficacy in combination with immune checkpoint blockade. Transl Oncol. 2021;14:101116 pubmed publisher
  29. Zheng W, Song H, Luo Z, Wu H, Chen L, Wang Y, et al. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  30. Melin N, Sánchez Taltavull D, Fahrner R, Keogh A, Dosch M, Büchi I, et al. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury. Cell Death Dis. 2021;12:366 pubmed publisher
  31. Joseph R, Soundararajan R, Vasaikar S, Yang F, Allton K, Tian L, et al. CD8+ T cells inhibit metastasis and CXCL4 regulates its function. Br J Cancer. 2021;125:176-189 pubmed publisher
  32. Santos Zas I, Lemari xe9 J, Zlatanova I, Cachanado M, Seghezzi J, Benamer H, et al. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021;12:1483 pubmed publisher
  33. Can xe8 S, Van Snick J, Uyttenhove C, Pilotte L, van den Eynde B. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism. J Immunother Cancer. 2021;9: pubmed publisher
  34. Hamminger P, Marchetti L, Preglej T, Platzer R, Zhu C, Kamnev A, et al. Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases. J Autoimmun. 2021;119:102610 pubmed publisher
  35. Henrich I, Jain K, Young R, Quick L, Lindsay J, Park D, et al. Ubiquitin-specific protease 6 functions as a tumor suppressor in Ewing Sarcoma through immune activation. Cancer Res. 2021;: pubmed publisher
  36. Kharkwal S, Johndrow C, Veerapen N, Kharkwal H, Saavedra Avila N, Carreño L, et al. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy. Cancer Res. 2021;81:1788-1801 pubmed publisher
  37. Brownlie D, Doughty Shenton D, Yh Soong D, Nixon C, O Carragher N, M Carlin L, et al. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β. J Immunother Cancer. 2021;9: pubmed publisher
  38. Break T, Oikonomou V, Dutzan N, Desai J, Swidergall M, Freiwald T, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371: pubmed publisher
  39. Grand M, Waqasi M, Demarta Gatsi C, Wei Y, Peronet R, Commere P, et al. Hepatic Inflammation Confers Protective Immunity Against Liver Stages of Malaria Parasite. Front Immunol. 2020;11:585502 pubmed publisher
  40. Pariser D, Hilt Z, Ture S, Blick Nitko S, Looney M, Cleary S, et al. Lung megakaryocytes are immune modulatory cells. J Clin Invest. 2021;131: pubmed publisher
  41. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  42. Bhaskar A, Kumar S, Khan M, Singh A, Dwivedi V, Nandicoori V. Host sirtuin 2 as an immunotherapeutic target against tuberculosis. elife. 2020;9: pubmed publisher
  43. Peligero Cruz C, Givony T, Sebé Pedrós A, Dobes J, Kadouri N, Nevo S, et al. IL18 signaling promotes homing of mature Tregs into the thymus. elife. 2020;9: pubmed publisher
  44. Ho J, Angel M, Ma Y, Sloan E, Wang G, Martínez Romero C, et al. Hybrid Gene Origination Creates Human-Virus Chimeric Proteins during Infection. Cell. 2020;181:1502-1517.e23 pubmed publisher
  45. Zhou S, Wu W, Wang Z, Wang Z, Su Q, Li X, et al. RelB regulates the homeostatic proliferation but not the function of Tregs. BMC Immunol. 2020;21:37 pubmed publisher
  46. Bekeschus S, Clemen R, Nießner F, Sagwal S, Freund E, Schmidt A. Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion. Adv Sci (Weinh). 2020;7:1903438 pubmed publisher
  47. Hajaj E, Eisenberg G, Klein S, Frankenburg S, Merims S, Ben David I, et al. SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. elife. 2020;9: pubmed publisher
  48. Wang J, Li P, Yu Y, Fu Y, Jiang H, Lu M, et al. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity. Science. 2020;367: pubmed publisher
  49. Yu M, Guo G, Huang L, Deng L, Chang C, Achyut B, et al. CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nat Commun. 2020;11:515 pubmed publisher
  50. Singh K, Leu J, Barnoud T, Vonteddu P, Gnanapradeepan K, Lin C, et al. African-centric TP53 variant increases iron accumulation and bacterial pathogenesis but improves response to malaria toxin. Nat Commun. 2020;11:473 pubmed publisher
  51. Reinhard K, Rengstl B, Oehm P, Michel K, Billmeier A, Hayduk N, et al. An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors. Science. 2020;367:446-453 pubmed publisher
  52. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  53. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  54. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  55. Li A, Herbst R, Canner D, Schenkel J, Smith O, Kim J, et al. IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development. Cell Rep. 2019;29:2998-3008.e8 pubmed publisher
  56. Hang S, Paik D, Yao L, Kim E, Jamma T, Lu J, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576:143-148 pubmed publisher
  57. Zhao Y, Yang Q, Jin C, Feng Y, Xie S, Xie H, et al. Changes of CD103-expressing pulmonary CD4+ and CD8+ T cells in S. japonicum infected C57BL/6 mice. BMC Infect Dis. 2019;19:999 pubmed publisher
  58. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed publisher
  59. Leone R, Zhao L, Englert J, Sun I, Oh M, Sun I, et al. Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion. Science. 2019;366:1013-1021 pubmed publisher
  60. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  61. Mani V, Bromley S, Aijö T, Mora Buch R, Carrizosa E, Warner R, et al. Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate. Science. 2019;366: pubmed publisher
  62. Benechet A, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature. 2019;574:200-205 pubmed publisher
  63. Majer O, Liu B, Kreuk L, Krogan N, Barton G. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019;575:366-370 pubmed publisher
  64. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  65. Nelson C, Thompson E, Quarnstrom C, Fraser K, Seelig D, Bhela S, et al. Robust Iterative Stimulation with Self-Antigens Overcomes CD8+ T Cell Tolerance to Self- and Tumor Antigens. Cell Rep. 2019;28:3092-3104.e5 pubmed publisher
  66. Dong M, Wang G, Chow R, Ye L, Zhu L, Dai X, et al. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178:1189-1204.e23 pubmed publisher
  67. Collins N, Han S, Enamorado M, Link V, Huang B, Moseman E, et al. The Bone Marrow Protects and Optimizes Immunological Memory during Dietary Restriction. Cell. 2019;178:1088-1101.e15 pubmed publisher
  68. Rosshart S, Herz J, Vassallo B, Hunter A, Wall M, Badger J, et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science. 2019;365: pubmed publisher
  69. Oh J, Iijima N, Song E, Lu P, Klein J, Jiang R, et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature. 2019;: pubmed publisher
  70. Qiu J, Villa M, Sanin D, Buck M, O Sullivan D, Ching R, et al. Acetate Promotes T Cell Effector Function during Glucose Restriction. Cell Rep. 2019;27:2063-2074.e5 pubmed publisher
  71. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  72. LaFleur M, Nguyen T, Coxe M, Yates K, Trombley J, Weiss S, et al. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system. Nat Commun. 2019;10:1668 pubmed publisher
  73. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  74. Visekruna A, Hartmann S, Sillke Y, Glauben R, Fischer F, Raifer H, et al. Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells. J Clin Invest. 2019;129:1972-1983 pubmed publisher
  75. Sinclair L, Howden A, Brenes A, Spinelli L, Hukelmann J, Macintyre A, et al. Antigen receptor control of methionine metabolism in T cells. elife. 2019;8: pubmed publisher
  76. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  77. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  78. Silva D, Yu S, Ulge U, Spangler J, Jude K, Labao Almeida C, et al. De novo design of potent and selective mimics of IL-2 and IL-15. Nature. 2019;565:186-191 pubmed publisher
  79. Mantri C, St John A. Immune synapses between mast cells and γδ T cells limit viral infection. J Clin Invest. 2019;129:1094-1108 pubmed publisher
  80. Bern M, Parikh B, Yang L, Beckman D, Poursine Laurent J, Yokoyama W. Inducible down-regulation of MHC class I results in natural killer cell tolerance. J Exp Med. 2019;216:99-116 pubmed publisher
  81. Vega Angeles V, Terrazas L, Ledesma Soto Y, Jimenez L, Landa A. Taenia solium glutathione transferase fraction activates macrophages and favors the development of Th1-type response. Biosci Rep. 2019;39: pubmed publisher
  82. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed publisher
  83. Chinta K, Rahman M, Saini V, Glasgow J, Reddy V, Lever J, et al. Microanatomic Distribution of Myeloid Heme Oxygenase-1 Protects against Free Radical-Mediated Immunopathology in Human Tuberculosis. Cell Rep. 2018;25:1938-1952.e5 pubmed publisher
  84. James K, Cosway E, LUCAS B, White A, Parnell S, Carvalho Gaspar M, et al. Endothelial cells act as gatekeepers for LTβR-dependent thymocyte emigration. J Exp Med. 2018;215:2984-2993 pubmed publisher
  85. Wilgenburg B, Loh L, Chen Z, Pediongco T, Wang H, Shi M, et al. MAIT cells contribute to protection against lethal influenza infection in vivo. Nat Commun. 2018;9:4706 pubmed publisher
  86. Sang A, Danhorn T, Peterson J, Rankin A, O Connor B, Leach S, et al. Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus. Nat Commun. 2018;9:3973 pubmed publisher
  87. Qu J, Li L, Xie H, Zhang X, Yang Q, Qiu H, et al. TLR3 Modulates the Response of NK Cells against Schistosoma japonicum. J Immunol Res. 2018;2018:7519856 pubmed publisher
  88. Qiao G, Bucsek M, Winder N, Chen M, Giridharan T, Olejniczak S, et al. β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress. Cancer Immunol Immunother. 2019;68:11-22 pubmed publisher
  89. Louveau A, Herz J, Alme M, Salvador A, Dong M, Viar K, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380-1391 pubmed publisher
  90. Ko Y, Chan Y, Liu C, Liang J, Chuang T, Hsueh Y, et al. Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M. Front Immunol. 2018;9:1828 pubmed publisher
  91. Xing S, Shao P, Li F, Zhao X, Seo W, Wheat J, et al. Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. J Exp Med. 2018;215:2211-2226 pubmed publisher
  92. Gu C, Borjabad A, Hadas E, Kelschenbach J, Kim B, Chao W, et al. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS Pathog. 2018;14:e1007061 pubmed publisher
  93. Moalli F, Ficht X, Germann P, Vladymyrov M, Stolp B, de Vries I, et al. The Rho regulator Myosin IXb enables nonlymphoid tissue seeding of protective CD8+ T cells. J Exp Med. 2018;215:1869-1890 pubmed publisher
  94. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed publisher
  95. Borlido J, Sakuma S, Raices M, Carrette F, Tinoco R, Bradley L, et al. Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nat Immunol. 2018;19:594-605 pubmed publisher
  96. Dipiazza A, Laniewski N, Rattan A, Topham D, Miller J, Sant A. CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection. J Virol. 2018;92: pubmed publisher
  97. Varelias A, Bunting M, Ormerod K, Koyama M, Olver S, Straube J, et al. Recipient mucosal-associated invariant T cells control GVHD within the colon. J Clin Invest. 2018;128:1919-1936 pubmed publisher
  98. Panda S, Facchinetti V, Voynova E, Hanabuchi S, Karnell J, Hanna R, et al. Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. J Clin Invest. 2018;128:1873-1887 pubmed publisher
  99. Xiao F, Ai G, Yan W, Wan X, Luo X, Ning Q. Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression. Cell Immunol. 2018;327:13-20 pubmed publisher
  100. Safya H, Mellouk A, Legrand J, Le Gall S, Benbijja M, Kanellopoulos Langevin C, et al. Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. Front Immunol. 2018;9:360 pubmed publisher
  101. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  102. Cortes J, Ambesi Impiombato A, Couronné L, Quinn S, Kim C, da Silva Almeida A, et al. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. Cancer Cell. 2018;33:259-273.e7 pubmed publisher
  103. Solanki A, Yanez D, Ross S, Lau C, Papaioannou E, Li J, et al. Gli3 in fetal thymic epithelial cells promotes thymocyte positive selection and differentiation by repression of Shh. Development. 2018;145: pubmed publisher
  104. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed publisher
  105. Turner D, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, et al. Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma. J Immunol. 2018;200:1561-1569 pubmed publisher
  106. Choi I, Wang Z, Ke Q, Hong M, Qian Y, Zhao X, et al. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses. Proc Natl Acad Sci U S A. 2018;115:E686-E695 pubmed publisher
  107. Cowan J, Baik S, McCarthy N, Parnell S, White A, Jenkinson W, et al. Aire controls the recirculation of murine Foxp3+ regulatory T-cells back to the thymus. Eur J Immunol. 2018;48:844-854 pubmed publisher
  108. Gaya M, Barral P, Burbage M, Aggarwal S, Montaner B, Warren Navia A, et al. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells. Cell. 2018;172:517-533.e20 pubmed publisher
  109. Glasner A, Isaacson B, Viukov S, Neuman T, Friedman N, Mandelboim M, et al. Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression. Sci Rep. 2017;7:13090 pubmed publisher
  110. Capece T, Walling B, Lim K, Kim K, Bae S, Chung H, et al. A novel intracellular pool of LFA-1 is critical for asymmetric CD8+ T cell activation and differentiation. J Cell Biol. 2017;216:3817-3829 pubmed publisher
  111. Danahy D, Anthony S, Jensen I, Hartwig S, Shan Q, Xue H, et al. Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells. PLoS Pathog. 2017;13:e1006569 pubmed publisher
  112. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  113. Alloatti A, Rookhuizen D, Joannas L, Carpier J, Iborra S, Magalhaes J, et al. Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity. J Exp Med. 2017;214:2231-2241 pubmed publisher
  114. Mendoza A, Fang V, Chen C, Serasinghe M, Verma A, Muller J, et al. Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells. Nature. 2017;546:158-161 pubmed publisher
  115. Torcellan T, Hampton H, Bailey J, Tomura M, Brink R, Chtanova T. In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors. Proc Natl Acad Sci U S A. 2017;114:5677-5682 pubmed publisher
  116. Miao T, Symonds A, Singh R, Symonds J, Ogbe A, Omodho B, et al. Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation. J Exp Med. 2017;214:1787-1808 pubmed publisher
  117. Bagchi S, He Y, Zhang H, Cao L, Van Rhijn I, Moody D, et al. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127:2339-2352 pubmed publisher
  118. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  119. Martinez Jimenez C, Eling N, Chen H, Vallejos C, Kolodziejczyk A, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science. 2017;355:1433-1436 pubmed publisher
  120. Getahun A, Wemlinger S, Rudra P, Santiago M, van Dyk L, Cambier J. Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway. J Exp Med. 2017;214:931-941 pubmed publisher
  121. González Pérez G, Lamousé Smith E. Gastrointestinal Microbiome Dysbiosis in Infant Mice Alters Peripheral CD8+ T Cell Receptor Signaling. Front Immunol. 2017;8:265 pubmed publisher
  122. Kogo H, Shimizu M, Negishi Y, Uchida E, Takahashi H. Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of ?-galactosylceramide in vivo. Immunology. 2017;151:324-339 pubmed publisher
  123. Baranek T, Morello E, Valayer A, Aimar R, Bréa D, Henry C, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Front Immunol. 2017;8:123 pubmed publisher
  124. Komegae E, Souza T, Grund L, Lima C, Lopes Ferreira M. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. PLoS ONE. 2017;12:e0171796 pubmed publisher
  125. Ying W, Wollam J, Ofrecio J, Bandyopadhyay G, El Ouarrat D, Lee Y, et al. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J Clin Invest. 2017;127:1019-1030 pubmed publisher
  126. Jiang X, Park C, Geddes Sweeney J, Yoo M, Gaide O, Kupper T. Dermal ?? T Cells Do Not Freely Re-Circulate Out of Skin and Produce IL-17 to Promote Neutrophil Infiltration during Primary Contact Hypersensitivity. PLoS ONE. 2017;12:e0169397 pubmed publisher
  127. van der Weyden L, Arends M, Campbell A, Bald T, Wardle Jones H, Griggs N, et al. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature. 2017;541:233-236 pubmed publisher
  128. Weindel C, Richey L, Mehta A, Shah M, Huber B. Autophagy in Dendritic Cells and B Cells Is Critical for the Inflammatory State of TLR7-Mediated Autoimmunity. J Immunol. 2017;198:1081-1092 pubmed publisher
  129. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  130. Li M, Li Z, Yao Y, Jin W, Wood K, Liu Q, et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity. Proc Natl Acad Sci U S A. 2017;114:E396-E405 pubmed publisher
  131. Hashimoto Hill S, Friesen L, Kim M, Kim C. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 2017;10:912-923 pubmed publisher
  132. Connor L, Tang S, Cognard E, Ochiai S, Hilligan K, Old S, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125-142 pubmed publisher
  133. Ma C, Mishra S, Demel E, Liu Y, Zhang N. TGF-? Controls the Formation of Kidney-Resident T Cells via Promoting Effector T Cell Extravasation. J Immunol. 2017;198:749-756 pubmed publisher
  134. Muschaweckh A, Buchholz V, Fellenzer A, Hessel C, König P, Tao S, et al. Antigen-dependent competition shapes the local repertoire of tissue-resident memory CD8+ T cells. J Exp Med. 2016;213:3075-3086 pubmed
  135. Khan S, Woodruff E, Trapecar M, Fontaine K, Ezaki A, Borbet T, et al. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016;213:2913-2929 pubmed
  136. Zamora Pineda J, Kumar A, Suh J, Zhang M, Saba J. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. J Exp Med. 2016;213:2773-2791 pubmed
  137. Zhao J, Chen C, Guo M, Tao Y, Cui P, Zhou Y, et al. MicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4. Front Immunol. 2016;7:389 pubmed
  138. Yu S, Pearson A, Lim R, Rodgers D, Li S, Parker H, et al. Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody-drug Conjugate. Mol Ther. 2016;24:2078-2089 pubmed publisher
  139. Gerriets V, Kishton R, Johnson M, Cohen S, Siska P, Nichols A, et al. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol. 2016;17:1459-1466 pubmed publisher
  140. Carnevale D, Perrotta M, Pallante F, Fardella V, Iacobucci R, Fardella S, et al. A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication. Nat Commun. 2016;7:13035 pubmed publisher
  141. Ishikawa E, Kosako H, Yasuda T, Ohmuraya M, Araki K, Kurosaki T, et al. Protein kinase D regulates positive selection of CD4+ thymocytes through phosphorylation of SHP-1. Nat Commun. 2016;7:12756 pubmed publisher
  142. Hrdinka M, Sudan K, Just S, Drobek A, Stepanek O, Schluter D, et al. Normal Development and Function of T Cells in Proline Rich 7 (Prr7) Deficient Mice. PLoS ONE. 2016;11:e0162863 pubmed publisher
  143. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  144. Akk A, Springer L, Pham C. Neutrophil Extracellular Traps Enhance Early Inflammatory Response in Sendai Virus-Induced Asthma Phenotype. Front Immunol. 2016;7:325 pubmed publisher
  145. Uhde A, Herder V, Akram Khan M, Ciurkiewicz M, Schaudien D, Teich R, et al. Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice. PLoS ONE. 2016;11:e0161883 pubmed publisher
  146. Hoegl S, Ehrentraut H, Brodsky K, Victorino F, Golden Mason L, Eltzschig H, et al. NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury. J Leukoc Biol. 2017;101:471-480 pubmed publisher
  147. Ushiki T, Huntington N, Glaser S, Kiu H, Georgiou A, Zhang J, et al. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells. PLoS ONE. 2016;11:e0162111 pubmed publisher
  148. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  149. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  150. Liu W, Kang S, Huang Z, Wu C, Jin H, Maine C, et al. A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells. J Exp Med. 2016;213:1901-19 pubmed publisher
  151. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed publisher
  152. Veinotte L, Gebremeskel S, Johnston B. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFN? production and tumor control. Oncoimmunology. 2016;5:e1160979 pubmed publisher
  153. Rex J, Albrecht U, Ehlting C, Thomas M, Zanger U, Sawodny O, et al. Model-Based Characterization of Inflammatory Gene Expression Patterns of Activated Macrophages. PLoS Comput Biol. 2016;12:e1005018 pubmed publisher
  154. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed publisher
  155. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed publisher
  156. Rackov G, Hernandez Jimenez E, Shokri R, Carmona Rodríguez L, Manes S, Alvarez Mon M, et al. p21 mediates macrophage reprogramming through regulation of p50-p50 NF-?B and IFN-?. J Clin Invest. 2016;126:3089-103 pubmed publisher
  157. Orta Mascaró M, Consuegra Fernández M, Carreras E, Roncagalli R, Carreras Sureda A, Alvarez P, et al. CD6 modulates thymocyte selection and peripheral T cell homeostasis. J Exp Med. 2016;213:1387-97 pubmed publisher
  158. Allison K, Sajti E, Collier J, Gosselin D, Troutman T, Stone E, et al. Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4+ T cells. elife. 2016;5: pubmed publisher
  159. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  160. De Grove K, Provoost S, Hendriks R, McKenzie A, Seys L, Kumar S, et al. Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs pollutant-induced allergic airway responses. J Allergy Clin Immunol. 2017;139:246-257.e4 pubmed publisher
  161. Goetz B, An W, Mohapatra B, Zutshi N, Iseka F, Storck M, et al. A novel CBL-Bflox/flox mouse model allows tissue-selective fully conditional CBL/CBL-B double-knockout: CD4-Cre mediated CBL/CBL-B deletion occurs in both T-cells and hematopoietic stem cells. Oncotarget. 2016;7:51107-51123 pubmed publisher
  162. Mkhikian H, Mortales C, Zhou R, Khachikyan K, Wu G, Haslam S, et al. Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis. elife. 2016;5: pubmed publisher
  163. Rao E, Zhang Y, Li Q, Hao J, Egilmez N, Suttles J, et al. AMPK-dependent and independent effects of AICAR and compound C on T-cell responses. Oncotarget. 2016;7:33783-95 pubmed publisher
  164. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  165. Rialdi A, Campisi L, Zhao N, Lagda A, Pietzsch C, Ho J, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 2016;352:aad7993 pubmed publisher
  166. Salao K, Jiang L, Li H, Tsai V, Husaini Y, Curmi P, et al. CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis. Biol Open. 2016;5:620-30 pubmed publisher
  167. Swamy M, Pathak S, Grzes K, Damerow S, Sinclair L, van Aalten D, et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat Immunol. 2016;17:712-20 pubmed publisher
  168. Verbist K, Guy C, Milasta S, Liedmann S, Kaminski M, Wang R, et al. Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. Nature. 2016;532:389-93 pubmed publisher
  169. Llopiz D, Aranda F, Díaz Valdés N, Ruiz M, Infante S, Belsue V, et al. Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccination. Oncoimmunology. 2016;5:e1075113 pubmed
  170. Mathewson N, Jenq R, Mathew A, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016;17:505-513 pubmed publisher
  171. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed publisher
  172. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed publisher
  173. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  174. Bulla R, Tripodo C, Rami D, Ling G, Agostinis C, Guarnotta C, et al. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun. 2016;7:10346 pubmed publisher
  175. Foks A, Engelbertsen D, Kuperwaser F, Alberts Grill N, Gonen A, Witztum J, et al. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Arterioscler Thromb Vasc Biol. 2016;36:456-65 pubmed publisher
  176. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed publisher
  177. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  178. Ito T, Itakura J, Takahashi S, Sato M, Mino M, Fushimi S, et al. Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia. Crit Care Med. 2016;44:e530-43 pubmed publisher
  179. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  180. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed publisher
  181. Chen S, Chang B, Chang S, Tong T, Ham S, Sherry B, et al. BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia. Leukemia. 2016;30:833-43 pubmed publisher
  182. Okada K, Sato S, Sato A, Mandelboim O, Yamasoba T, Kiyono H. Identification and Analysis of Natural Killer Cells in Murine Nasal Passages. PLoS ONE. 2015;10:e0142920 pubmed publisher
  183. Fontinha D, Lopes F, Marques S, Alenquer M, Simas J. Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS ONE. 2015;10:e0142540 pubmed publisher
  184. Verma S, Weiskopf D, Gupta A, McDonald B, Peters B, Sette A, et al. Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection. J Virol. 2016;90:650-8 pubmed publisher
  185. Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015;21:1272-9 pubmed publisher
  186. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed publisher
  187. Black L, Srivastava R, Schoeb T, Moore R, Barnes S, KABAROWSKI J. Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice. J Immunol. 2015;195:4685-98 pubmed publisher
  188. Riquelme S, Pogu J, Anegon I, Bueno S, Kalergis A. Carbon monoxide impairs mitochondria-dependent endosomal maturation and antigen presentation in dendritic cells. Eur J Immunol. 2015;45:3269-88 pubmed publisher
  189. Pohar J, Lainšček D, Fukui R, Yamamoto C, Miyake K, Jerala R, et al. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9. J Immunol. 2015;195:4396-405 pubmed publisher
  190. Joly A, Deepti A, Seignez A, Goloudina A, Hebrard S, Schmitt E, et al. The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development. Oncogene. 2016;35:2842-51 pubmed publisher
  191. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed publisher
  192. Kaminsky L, Sei J, Parekh N, Davies M, Reider I, Krouse T, et al. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection. J Virol. 2015;89:9974-85 pubmed publisher
  193. Li Y, Shen C, Zhu B, Shi F, Eisen H, Chen J. Persistent Antigen and Prolonged AKT-mTORC1 Activation Underlie Memory CD8 T Cell Impairment in the Absence of CD4 T Cells. J Immunol. 2015;195:1591-8 pubmed publisher
  194. Vogel A, Brown D. Single-Dose CpG Immunization Protects Against a Heterosubtypic Challenge and Generates Antigen-Specific Memory T Cells. Front Immunol. 2015;6:327 pubmed publisher
  195. Weindel C, Richey L, Bolland S, Mehta A, Kearney J, Huber B. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation. Autophagy. 2015;11:1010-24 pubmed publisher
  196. Sasaki K, Takada K, Ohte Y, Kondo H, Sorimachi H, Tanaka K, et al. Thymoproteasomes produce unique peptide motifs for positive selection of CD8(+) T cells. Nat Commun. 2015;6:7484 pubmed publisher
  197. Deppisch N, Ruf P, Eissler N, Neff F, Buhmann R, Lindhofer H, et al. Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery. Mol Cancer Ther. 2015;14:1877-83 pubmed publisher
  198. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration. PLoS ONE. 2015;10:e0128094 pubmed publisher
  199. Vinue A, Andrés Blasco I, Herrero Cervera A, Piqueras L, Andres V, Burks D, et al. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling. Biochim Biophys Acta. 2015;1852:1729-42 pubmed publisher
  200. Deberge M, Ely K, Wright P, Thorp E, Enelow R. Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. J Leukoc Biol. 2015;98:423-34 pubmed publisher
  201. Lu K, Keppler S, Leithäuser F, Mattfeldt T, Castello A, Kostezka U, et al. Nck adaptor proteins modulate differentiation and effector function of T cells. J Leukoc Biol. 2015;98:301-11 pubmed publisher
  202. Shao L, Lie A, Zhang Y, Wong C, Kwong Y. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease. Ann Hematol. 2015;94:1493-504 pubmed publisher
  203. Olguín J, Fernández J, Salinas N, Juárez I, Rodriguez Sosa M, Campuzano J, et al. Adoptive transfer of CD4(+)Foxp3(+) regulatory T cells to C57BL/6J mice during acute infection with Toxoplasma gondii down modulates the exacerbated Th1 immune response. Microbes Infect. 2015;17:586-95 pubmed publisher
  204. Hamilton J, Li J, Wu Q, Yang P, Luo B, Li H, et al. General Approach for Tetramer-Based Identification of Autoantigen-Reactive B Cells: Characterization of La- and snRNP-Reactive B Cells in Autoimmune BXD2 Mice. J Immunol. 2015;194:5022-34 pubmed publisher
  205. Rouhani S, Eccles J, Riccardi P, Peske J, Tewalt E, Cohen J, et al. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction. Nat Commun. 2015;6:6771 pubmed publisher
  206. Charlton J, Tsoukatou D, Mamalaki C, Chatzidakis I. Programmed death 1 regulates memory phenotype CD4 T cell accumulation, inhibits expansion of the effector memory phenotype subset and modulates production of effector cytokines. PLoS ONE. 2015;10:e0119200 pubmed publisher
  207. Nishikado H, Fujimura T, Taka H, Mineki R, Ogawa H, Okumura K, et al. Cysteine protease antigens cleave CD123, the α subunit of murine IL-3 receptor, on basophils and suppress IL-3-mediated basophil expansion. Biochem Biophys Res Commun. 2015;460:261-6 pubmed publisher
  208. Rao E, Zhang Y, Zhu G, Hao J, Persson X, Egilmez N, et al. Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death. Oncotarget. 2015;6:7944-58 pubmed
  209. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  210. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  211. Zhan R, Han Q, Zhang C, Tian Z, Zhang J. Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection. Infect Immun. 2015;83:1641-9 pubmed publisher
  212. Stack G, Jones E, Marsden M, Stacey M, Snelgrove R, Lacaze P, et al. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog. 2015;11:e1004641 pubmed publisher
  213. Michelet X, Garg S, Wolf B, Tuli A, Ricciardi Castagnoli P, Brenner M. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b. J Immunol. 2015;194:2079-88 pubmed publisher
  214. Huang Y, Clarke F, Karimi M, Roy N, Williamson E, Okumura M, et al. CRK proteins selectively regulate T cell migration into inflamed tissues. J Clin Invest. 2015;125:1019-32 pubmed publisher
  215. Evans E, Jonason A, Bussler H, Torno S, Veeraraghavan J, Reilly C, et al. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunol Res. 2015;3:689-701 pubmed publisher
  216. Wirsdörfer F, Bangen J, Pastille E, Hansen W, Flohé S. Breaking the co-operation between bystander T-cells and natural killer cells prevents the development of immunosuppression after traumatic skeletal muscle injury in mice. Clin Sci (Lond). 2015;128:825-38 pubmed publisher
  217. Briercheck E, Trotta R, Chen L, Hartlage A, Cole J, Cole T, et al. PTEN is a negative regulator of NK cell cytolytic function. J Immunol. 2015;194:1832-40 pubmed publisher
  218. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  219. Yuan X, Dee M, Altman N, Malek T. IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa. J Immunol. 2015;194:1334-46 pubmed publisher
  220. Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE. 2014;9:e115198 pubmed publisher
  221. LUCAS B, White A, Ulvmar M, Nibbs R, Sitnik K, Agace W, et al. CCRL1/ACKR4 is expressed in key thymic microenvironments but is dispensable for T lymphopoiesis at steady state in adult mice. Eur J Immunol. 2015;45:574-83 pubmed publisher
  222. Hartung E, Becker M, Bachem A, Reeg N, Jäkel A, Hutloff A, et al. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1. J Immunol. 2015;194:1069-79 pubmed publisher
  223. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  224. Yin Y, Qin T, Wang X, Lin J, Yu Q, Yang Q. CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites. Mucosal Immunol. 2015;8:799-814 pubmed publisher
  225. Nacer A, Movila A, Sohet F, Girgis N, Gundra U, Loke P, et al. Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. PLoS Pathog. 2014;10:e1004528 pubmed publisher
  226. Guo X, Tanaka Y, Kondo M. Thymic precursors of TCRαβ(+)CD8αα(+) intraepithelial lymphocytes are negative for CD103. Immunol Lett. 2015;163:40-8 pubmed publisher
  227. Thueson L, Emmons T, Browning D, Kreitinger J, Shepherd D, Wetzel S. In vitro exposure to the herbicide atrazine inhibits T cell activation, proliferation, and cytokine production and significantly increases the frequency of Foxp3+ regulatory T cells. Toxicol Sci. 2015;143:418-29 pubmed publisher
  228. Fahl S, Harris B, Coffey F, Wiest D. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint. J Immunol. 2015;194:200-9 pubmed
  229. Mehta P, Nuotio Antar A, Smith C. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2015;97:121-34 pubmed publisher
  230. McKinstry K, Strutt T, Bautista B, Zhang W, Kuang Y, Cooper A, et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun. 2014;5:5377 pubmed publisher
  231. Dang V, Tanabe K, Tanaka Y, Tokumoto N, Misumi T, Saeki Y, et al. Fasting enhances TRAIL-mediated liver natural killer cell activity via HSP70 upregulation. PLoS ONE. 2014;9:e110748 pubmed publisher
  232. McDonnell A, Lesterhuis W, Khong A, Nowak A, Lake R, Currie A, et al. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol. 2015;45:49-59 pubmed publisher
  233. Döring M, Lessin I, Frenz T, Spanier J, Kessler A, Tegtmeyer P, et al. M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells. J Virol. 2014;88:13638-50 pubmed publisher
  234. Naik E, Webster J, DeVoss J, Liu J, Suriben R, Dixit V. Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947-55 pubmed publisher
  235. Burton B, Britton G, Fang H, Verhagen J, Smithers B, Sabatos Peyton C, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun. 2014;5:4741 pubmed publisher
  236. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  237. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  238. Lo Sasso G, Menzies K, Mottis A, Piersigilli A, Perino A, Yamamoto H, et al. SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis. PLoS ONE. 2014;9:e103573 pubmed publisher
  239. Céspedes P, Bueno S, Ramírez B, Gómez R, Riquelme S, Palavecino C, et al. Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci U S A. 2014;111:E3214-23 pubmed publisher
  240. Cowan J, McCarthy N, Parnell S, White A, Bacon A, Serge A, et al. Differential requirement for CCR4 and CCR7 during the development of innate and adaptive ??T cells in the adult thymus. J Immunol. 2014;193:1204-12 pubmed publisher
  241. Au Yeung B, Melichar H, Ross J, Cheng D, Zikherman J, Shokat K, et al. Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development. Nat Immunol. 2014;15:687-94 pubmed publisher
  242. Geem D, Medina Contreras O, McBride M, Newberry R, Koni P, Denning T. Specific microbiota-induced intestinal Th17 differentiation requires MHC class II but not GALT and mesenteric lymph nodes. J Immunol. 2014;193:431-8 pubmed publisher
  243. Pick J, Arra A, Lingel H, Hegel J, Huber M, Nishanth G, et al. CTLA-4 (CD152) enhances the Tc17 differentiation program. Eur J Immunol. 2014;44:2139-52 pubmed publisher
  244. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed publisher
  245. Jayaraman A, Jackson D, Message S, Pearson R, Aniscenko J, Caramori G, et al. IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection. Mucosal Immunol. 2014;7:1151-64 pubmed publisher
  246. Joedicke J, Dietze K, Zelinskyy G, Dittmer U. The phenotype and activation status of regulatory T cells during Friend retrovirus infection. Virol Sin. 2014;29:48-60 pubmed publisher
  247. Kim E, Gasper D, Lee S, Plisch E, Svaren J, Suresh M. Bach2 regulates homeostasis of Foxp3+ regulatory T cells and protects against fatal lung disease in mice. J Immunol. 2014;192:985-95 pubmed publisher
  248. Salem H, Trojanowski B, Fiedler K, Maier H, Schirmbeck R, Wagner M, et al. Long-term IKK2/NF-?B signaling in pancreatic ?-cells induces immune-mediated diabetes. Diabetes. 2014;63:960-75 pubmed publisher
  249. Gujar S, Clements D, Dielschneider R, Helson E, Marcato P, Lee P. Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms. Br J Cancer. 2014;110:83-93 pubmed publisher
  250. Fu G, Casas J, Rigaud S, Rybakin V, Lambolez F, Brzostek J, et al. Themis sets the signal threshold for positive and negative selection in T-cell development. Nature. 2013;504:441-5 pubmed publisher
  251. Kłossowicz M, Scirka B, Suchanek J, Marek Bukowiec K, Kisielow P, Aguado E, et al. Assessment of caspase mediated degradation of linker for activation of T cells (LAT) at a single cell level. J Immunol Methods. 2013;389:9-17 pubmed publisher
  252. Mathew R, Seiler M, Scanlon S, Mao A, Constantinides M, Bertozzi Villa C, et al. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature. 2012;491:618-21 pubmed publisher
  253. Barral P, Sanchez Nino M, Van Rooijen N, Cerundolo V, Batista F. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J. 2012;31:2378-90 pubmed publisher
  254. Wollenberg I, Agua Doce A, Hernandez A, Almeida C, Oliveira V, Faro J, et al. Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J Immunol. 2011;187:4553-60 pubmed publisher
  255. Zou Y, Chen T, Han M, Wang H, Yan W, Song G, et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;184:466-75 pubmed publisher
  256. Blumenthal A, Kobayashi T, Pierini L, Banaei N, Ernst J, Miyake K, et al. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell Host Microbe. 2009;5:35-46 pubmed publisher
  257. Park S, Han Y, Aleyas A, George J, Yoon H, Lee J, et al. Low-dose antigen-experienced CD4+ T cells display reduced clonal expansion but facilitate an effective memory pool in response to secondary exposure. Immunology. 2008;123:426-37 pubmed
  258. Bliss S, Bliss S, Beiting D, Alcaraz A, Appleton J. IL-10 regulates movement of intestinally derived CD4+ T cells to the liver. J Immunol. 2007;178:7974-83 pubmed
  259. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A. 2007;81:652-62 pubmed
  260. Hale J, Boursalian T, Turk G, Fink P. Thymic output in aged mice. Proc Natl Acad Sci U S A. 2006;103:8447-52 pubmed
  261. Vanasek T, Nandiwada S, Jenkins M, Mueller D. CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. J Immunol. 2006;176:5880-9 pubmed
  262. Krieg C, Han P, Stone R, Goularte O, Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175:6420-7 pubmed